$25.99 Million in Sales Expected for Marchex, Inc. (NASDAQ:MCHX) This Quarter

Equities analysts expect Marchex, Inc. (NASDAQ:MCHX) to announce $25.99 million in sales for the current quarter, Zacks Investment Research reports. Two analysts have made estimates for Marchex’s earnings, with the lowest sales estimate coming in at $25.97 million and the highest estimate coming in at $26.00 million. Marchex posted sales of $23.13 million during the same quarter last year, which would suggest a positive year-over-year growth rate of 12.4%. The business is expected to issue its next earnings report on Wednesday, February 12th.

On average, analysts expect that Marchex will report full year sales of $103.51 million for the current financial year, with estimates ranging from $103.50 million to $103.51 million. For the next fiscal year, analysts forecast that the company will post sales of $103.62 million, with estimates ranging from $103.30 million to $103.94 million. Zacks Investment Research’s sales averages are a mean average based on a survey of research firms that that provide coverage for Marchex.

Marchex (NASDAQ:MCHX) last issued its quarterly earnings data on Wednesday, November 6th. The technology company reported ($0.02) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.04) by $0.02. Marchex had a negative net margin of 4.24% and a negative return on equity of 0.58%. The company had revenue of $24.79 million for the quarter, compared to the consensus estimate of $24.05 million.

Several research analysts have weighed in on MCHX shares. Zacks Investment Research raised Marchex from a “hold” rating to a “buy” rating and set a $3.50 price target on the stock in a research report on Wednesday, October 9th. ValuEngine raised Marchex from a “sell” rating to a “hold” rating in a research report on Friday, November 8th. One equities research analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus target price of $5.83.

In other news, CEO Jeff Baxter acquired 150,000 shares of the firm’s stock in a transaction on Monday, September 30th. The shares were purchased at an average cost of $0.61 per share, with a total value of $91,500.00. Also, major shareholder Edenbrook Capital, Llc acquired 41,400 shares of the firm’s stock in a transaction on Thursday, November 14th. The stock was purchased at an average cost of $4.15 per share, for a total transaction of $171,810.00. The disclosure for this purchase can be found here. Over the last ninety days, insiders acquired 389,417 shares of company stock worth $998,233. Insiders own 18.43% of the company’s stock.

Several large investors have recently added to or reduced their stakes in the company. Tower Research Capital LLC TRC purchased a new position in Marchex during the 2nd quarter valued at about $45,000. AMP Capital Investors Ltd purchased a new position in shares of Marchex in the second quarter valued at $62,000. Cubist Systematic Strategies LLC purchased a new position in shares of Marchex in the second quarter valued at $92,000. Stone Ridge Asset Management LLC purchased a new position in shares of Marchex in the second quarter valued at $114,000. Finally, Rhumbline Advisers grew its position in shares of Marchex by 15.3% in the third quarter. Rhumbline Advisers now owns 37,895 shares of the technology company’s stock valued at $119,000 after purchasing an additional 5,022 shares in the last quarter. Hedge funds and other institutional investors own 55.49% of the company’s stock.

Marchex stock traded down $0.04 during midday trading on Friday, hitting $3.92. 115,464 shares of the company’s stock were exchanged, compared to its average volume of 129,217. Marchex has a 12-month low of $2.51 and a 12-month high of $5.57. The company has a debt-to-equity ratio of 0.06, a quick ratio of 4.28 and a current ratio of 4.28. The stock has a market cap of $173.23 million, a price-to-earnings ratio of -65.33 and a beta of 1.56. The firm’s 50 day simple moving average is $3.62 and its 200 day simple moving average is $3.93.

Marchex Company Profile

Marchex, Inc operates as a call analytics company that helps businesses connect, drive, measure, and convert callers into customers. Its products include Marchex Call Analytics, an analytics platform for enterprises that depend on inbound phone calls to drive sales, appointments, and reservations; Marchex Speech Analytics that enable actionable insights for enterprise, mid-sized, and small businesses; Text Analytics and Communications, which enable businesses to send and receive text/SMS messages with customers; Call Monitoring; Marchex Omnichannel Analytics Cloud products, such as Marchex Search Analytics, a product for search marketers that drive phone calls from search campaigns, as well as Marchex Display and Video Analytics, a product for marketers that buy digital display advertising; Marchex Site Analytics, a product for marketers that can drive phone calls from Websites; and Marchex Social Analytics, a product for marketers that buy social media advertising.

See Also: Price-Sales Ratio

Get a free copy of the Zacks research report on Marchex (MCHX)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Marchex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Marchex and related companies with MarketBeat.com's FREE daily email newsletter.